Kraig Biocraft Laboratories Inc (KBLB)

[Jobrano]

press conference within the next two to three weeks

2010-09-16 06:05 ET - News Release

LANSING, MI -- (MARKET WIRE) -- 09/16/10

Kraig Biocraft Laboratories, Inc. (OTCBB: KBLB) announced that a research report on the Company has been issued by Emerging Growth Research. The full report can be accessed at http://bit.ly/9NZ4LP

Kraig Biocraft Laboratories recently announced the successful creation of genetically engineered silkworms with select spider silk genes.

The Company also recently announced plans to hold a press conference within the next two to three weeks to discuss further significant laboratory developments. The Company is currently planning the details of its upcoming press conference, and will provide further updates as soon as they become available.

Kraig Biocraft Laboratories is a biotechnology company focused on the development of commercially significant high performance fibers including spider silk.

For more information on Kraig Biocraft Laboratories please visit the Company's web site: http://www.KraigLabs.com

Statements in this press release about the company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "hopes," "develops," "researching," "research," "potential," "could" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals should all be considered forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Management cautions that its ability to further its research, and create commercially-viable products may be affected by the competitive environment, the Company's financial condition and its ability to raise sufficient capital to meet the financial obligations of its business plan and to fund its continuing operations.

CONTACT:

Ben Hansel

[phone]